Healthcare


 PGC, MVF, AJJ: Healthcare penny stocks with decent price returns in last 52 weeks

PGC, MVF, AJJ: Healthcare penny stocks with decent price returns in last 52 weeks

June 30, 2022 05:43 PM AEST| By Aditi Sarkar

Highlights,Over the last five days, the S&P/ASX200 has gained 1.82% but is down 10.7% over the last 52 weeks,The benchmark of the healthcare index, the S&P/ASX 200 Health Care, is down 11.16% over the last 52 weeks,Paragon offers a generous dividend...

 RSH, AVR, NTI: Best performing ASX healthcare equipment stocks in June

RSH, AVR, NTI: Best performing ASX healthcare equipment stocks in June

June 28, 2022 12:03 PM AEST| By Aditi Sarkar

Highlights,The S&P/ASX 200 Health Care closed on Monday with a gain of 1.25%.,The healthcare index has lost 1.55% over this month.,RSH, AVR, and NTI are three stocks from ASX healthcare that have outperformed the healthcare index and are up by more t...

 CGS, GLH, PME: ASX healthtech stocks with modest 3-year returns

CGS, GLH, PME: ASX healthtech stocks with modest 3-year returns

June 27, 2022 07:01 PM AEST| By Aditi Sarkar

Highlights,The fast-paced digital transformation has revolutionised the healthcare sector,Technology is penetrating all aspects of healthcare services, be it staff and facility management or patient care and diagnosis,This month Pro Medicus (ASX: PME...

 What is boosting CSL Limited’s (ASX:CSL) share price?

What is boosting CSL Limited’s (ASX:CSL) share price?

June 23, 2022 05:37 PM AEST| By Sukriti Nair

iggest ASX-listed healthcare stock, CSL Limited (ASX:CSL) has turned north recently. In last five trade days, CSL share price has gained 4.67%. CSL shares have notably moved up from their three-month low-price level. Despite delays in the acquisitio...

 RMD, CSL, COH, VRT: How are these healthcare stocks faring at ASX?

RMD, CSL, COH, VRT: How are these healthcare stocks faring at ASX?

June 22, 2022 03:40 PM AEST| By Priyanka Payal

The Australian share market opened on a positive note today as the ASX200 was up 0.108% at 6530.900 points at 11:57 AM AEST. Eight of 11 sectors are higher today, where the Utilities, energy and healthcare are the best performers.

 ResApp (ASX:RAP) shares nosedive 33% today; here’s why

ResApp (ASX:RAP) shares nosedive 33% today; here’s why

June 21, 2022 02:54 PM AEST| By Sonal Goyal

Highlights ResApp’s ‘not so positive’ COVID-19 data confirmatory study results are dragging the share price down on ASX. The unfavourable study outcome has also resulted in a drop in the scheme consideration from Pfizer. The .....

 Volpara (ASX:VHT) inks deal with Microsoft, here’s how shares reacted

Volpara (ASX:VHT) inks deal with Microsoft, here’s how shares reacted

June 21, 2022 01:37 PM AEST| By Sonal Goyal

Digital health solutions developer, Volpara Health Technologies Limited (ASX:VHT) shared today that it has joined hands with Microsoft to speed up the research and development of the products that detect breast arterial calcifications (BACs). Volp.....

 CSL, RHC, VRT: ASX healthcare stocks with sustainable returns

CSL, RHC, VRT: ASX healthcare stocks with sustainable returns

June 16, 2022 03:37 PM AEST| By Aditi Sarkar

Highlights The S&P/ASX200 hit a new 52-week low on Wednesday The year-to-date, one-year, and three-year returns of the S&P/ASX200 Health Care stand at 14.76%, -14.71% and 4.94%, respectively CSL, Ramsay, and Virtus are some stocks from.....

 SW1, SNZ, HSC : How are these ASX aged care stocks faring?

SW1, SNZ, HSC : How are these ASX aged care stocks faring?

June 16, 2022 11:53 AM AEST| By Aditi Sarkar

Highlights The 2022-23 budget of Australia invested AU$522 million in the aged care reforms Swift Networks implemented an agreement with Hubify Limited worth AU$1.5 million In 2021, SNZ reported a 136% increment in net profit after tax In May.....

 ResMed (ASX:RMD) to acquire MEDIFOX DAN in US$1.0B deal

ResMed (ASX:RMD) to acquire MEDIFOX DAN in US$1.0B deal

June 15, 2022 03:25 PM AEST| By Sonal Goyal

Medical device manufacturing company, ResMed Inc (ASX:RMD), has shared on Wednesday, that it will acquire MEDIFOX DAN for US$1.0 billion, under a definitive agreement. MEDIFOX DAN is a leader in out-of-hospital software solutions providers. ResMed.....

 Pro Medicus (ASX:PME) inks two contract renewals worth AU$47M

Pro Medicus (ASX:PME) inks two contract renewals worth AU$47M

June 14, 2022 01:24 PM AEST| By Sonal Goyal

Highlights Pro Medicus has signed a renewal contract with Sutter Health for another seven years. A renewal contract is also inked with Wellspan Health for further five years. The share price of Pro Medicus has gained by over 650% in last 5 yea.....

 Healthcare value stocks from ASX All Ordinaries: HLS, MVF, SHL, ANN

Healthcare value stocks from ASX All Ordinaries: HLS, MVF, SHL, ANN

June 13, 2022 12:07 AM AEST| By Aditi Sarkar

Highlights Value stocks trade at a lower price corresponding to their fundamentals A high dividend yield and low P/B P/E ratios are common features of value stocks Healius reported a 100% increment in underlying unaudited EBITDA YTD to May 202.....

 Pro Medicus signs US$28M contract with Allina Health; how are shares faring?

Pro Medicus signs US$28M contract with Allina Health; how are shares faring?

June 02, 2022 10:54 AM AEST| By Ashish

Highlights Pro Medicus signed a 7-year contract with a Minneapolis-based firm Allina Health. The deal with Alline Health is worth AU$28 million. The deal is expected to provide a unified diagnostic imaging platform across the network...

 Recent updates from ASX healthcare stocks DXB and GLH

Recent updates from ASX healthcare stocks DXB and GLH

June 01, 2022 04:01 PM AEST| By Aditi Sarkar

Highlights Dimerix recruits the first subject for its DMX-200 phase 3 trial in patients with FSGS kidney disease. FSGS has a huge market opportunity as in the US alone, end stage renal failure amounted to an estimated cost of US$55 billion per .....

 Mesoblast (ASX:MSB) posts US$23.1M third-quarter loss; how are shares faring?

Mesoblast (ASX:MSB) posts US$23.1M third-quarter loss; how are shares faring?

June 01, 2022 11:14 AM AEST| By Ashish

Highlights Mesoblast’s loss after tax for the third quarter FY2022 was US$21.3 million. Total revenue rose 5% from the comparative quarter last year to US$2 million. Despite the loss, Mesoblast’s share price was trading a...

 CSL, RHC, SHL: 3 ASX health care stocks on investors’ watchlist  

CSL, RHC, SHL: 3 ASX health care stocks on investors’ watchlist  

May 31, 2022 02:20 PM AEST| By Aditi Sarkar

Highlights CSL has the largest market capitalisation (AU$131.32 billion) in the ASX health care space as of 31 May 2022 In 2020/21, CSL invested US$1,001 million in R&D activities Sonic reported revenue growth of 7% and net profit growth o.....

 A look at 2 ASX-listed dental care stocks: SDI, PSQ

A look at 2 ASX-listed dental care stocks: SDI, PSQ

May 31, 2022 11:54 AM AEST| By Aditi Sarkar

Highlights Private dental clinics cater to more than 85% of dental care in Australia. Dental care stock SDI, which registered record 1H sales, expects new product releases and continued increases in market share to underpin growth momentum. CO.....

 RAC, CTE, ADO: ASX health stocks with massive returns in past 3 years

RAC, CTE, ADO: ASX health stocks with massive returns in past 3 years

May 28, 2022 12:45 AM AEST| By Aditi Sarkar

Multibaggers are lucrative stocks that provide returns several times higher than their initial investment value. To be more specific, if a stock price rises by double, it's called a double bagger, while if the price grows multiple times, it's calle.....

 From REG to ICR: Latest updates from ASX-listed aged care stocks

From REG to ICR: Latest updates from ASX-listed aged care stocks

May 26, 2022 07:37 PM AEST| By Aditi Sarkar

Highlights The Australian government provides funding to a range of aged care homes Regis Healthcare provides care for over 7,200 people throughout Australia Swift Networks has secured a new agreement worth AU$1.5 million with Hubify Limited .....

 Volpara Health (ASX:VHT) exceeds revenue guidance in FY22

Volpara Health (ASX:VHT) exceeds revenue guidance in FY22

May 26, 2022 12:13 PM AEST| By Sonal Goyal

Highlights Volpara marked 32% increase in revenue from customer contracts to NZ$26.1 million. Volpara delivered gross profit margin of over 91% in FY22. Volpara recorded 45% surge in the cash receipts. Health care technology provider, Vol.....

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.